Driehaus Capital Management’s CVS Health CVS Stock Holding History

Driehaus Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,962	Closed	-$274K	–	363
2022 Q2	$274K	Sell	2,962 -13	-0.4%	-$1.27K	﹤0.01%	329
2022 Q1	$301K	Buy	2,975 +170	+6%	+$17.9K	﹤0.01%	359
2021 Q4	$289K	Buy	+2,805	New	+$259K	﹤0.01%	350
2019 Q3	–	Sell	-5,710	Closed	-$311K	–	500
2019 Q2	$311K	Buy	+5,710	New	+$307K	0.01%	417
2018 Q4	–	Sell	-11,439	Closed	-$900K	–	432
2018 Q3	$900K	Sell	11,439 -4,484	-28%	-$321K	0.03%	360
2018 Q2	$1.02M	Buy	+15,923	New	+$1.05M	0.03%	342
2016 Q4	–	Sell	-16,856	Closed	-$1.5M	–	555
2016 Q3	$1.5M	Sell	16,856 -17,241	-51%	-$1.63M	0.05%	306
2016 Q2	$3.26M	Sell	34,097 -17,627	-34%	-$1.76M	0.12%	186
2016 Q1	$5.37M	Sell	51,724 -8,113	-14%	-$789K	0.17%	119
2015 Q4	$5.85M	Buy	59,837 +10,335	+21%	+$1.01M	0.2%	113
2015 Q3	$4.78M	Buy	49,502 +11,921	+32%	+$1.25M	0.17%	143
2015 Q2	$3.94M	Buy	37,581 +11,693	+45%	+$1.19M	0.14%	187
2015 Q1	$2.67M	Buy	+25,888	New	+$2.62M	0.09%	275

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Driehaus Capital Management's CVS Position: Q3 2022 in Review

Driehaus Capital Management sold out of CVS Health (CVS) in Q3 2022, closing a stake of 2,962 shares — an estimated $274K sold.

Driehaus Capital Management first reported a position in CVS in Q1 2015 and held it in 13 quarters. The position peaked at $5.85M in Q4 2015. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

Driehaus Capital Management reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
Driehaus Capital Management sold 2,962 CVS Health shares in Q3 2022, an estimated $274K.
Driehaus Capital Management first reported a position in CVS Health in Q1 2015 and held it in 13 quarters.
Driehaus Capital Management's CVS Health position peaked at $5.85M in Q4 2015.
2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.